Selected Publications

  1. Gopalakrishnan M, Amaria RN. Project Optimus Elicits the “Holistic” Benefits of PK/PD Modeling of Immunotherapy. Clin Cancer Res 2024;30:2862–4. https://doi.org/10.1158/1078-0432.CCR-24-0553
  2. Chamzas A, Tellez E, SyBing A, Gobburu JVS, Gopalakrishnan M. Optimizing tacrolimus dosing in Hispanic renal transplant patients: insights from real-world data. Front Pharmacol. 2024 Sep 19;15:1443988. doi: 10.3389/fphar.2024.1443988. PMID: 39364052; PMCID: PMC11446860.
  3. Shenkoya B, Gopalakrishnan M, Eke AC. Physiologically based pharmacokinetic modeling of long-acting extended-release naltrexone in pregnant women with opioid use disorder. CPT Pharmacometrics Syst Pharmacol. 2024 Nov;13(11):1939-1952. doi: 10.1002/psp4.13252. Epub 2024 Oct 9. PMID: 39380562; PMCID: PMC11578127.
  4. Langevin B, Gopalakrishnan M, Kuttamperoor J, Van Den Anker J, Murphy J, Arcaro KF, et al. The MILK study: Investigating intergenerational transmission of low-calorie sweeteners in breast milk. Contemp Clin Trials Commun 2023;36:101212. https://doi.org/10.1016/j.conctc.2023.101212.
  5. Langevin B, Gobburu JVS, Gopalakrishnan M. Is There a Need for a Dedicated Pharmacokinetic Trial for a Drug in Obese Populations? A Drug Prioritization Decision Tree Framework. J Clin Pharmacol 2023;63 Suppl 2:S48–64. https://doi.org/10.1002/jcph.2304.
  6. Salem AM, Niu T, Li C, Moffett BS, Ivaturi V, Gopalakrishnan M. Reassessing the Pediatric Dosing Recommendations for Unfractionated Heparin Using Real-World Data: A Pharmacokinetic-Pharmacodynamic Modeling Approach. J Clin Pharmacol. Published online November 23, 2021. PMID: 34816442
  7. Wijekoon N, Aduroja O, Biggs JM, El‐Metwally D, Gopalakrishnan M. Model‐Based Approach to Improve Clinical Outcomes in Neonates With Opioid Withdrawal Syndrome Using Real‐World Data. Clin Pharmacol Ther. 2021;109(1):243-252
  8. Kalaria SN, Armahizer M, McCarthy P, Badjatia N, Gobburu JV, Gopalakrishnan M. A Practice-Based, Clinical Pharmacokinetic Study to Inform Levetiracetam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration (PADRE-01). Clin Transl Sci. 2020;13(5):950-959
  9. Kalaria SN, Gopalakrishnan M, Heil EL. A Population Pharmacokinetics and Pharmacodynamic Approach To Optimize Tazobactam Activity in Critically Ill Patients. Antimicrob Agents Chemother. 2020;64(3): e02093-19
  10. Gopalakrishnan M, Zhu H, Farchione TR, et al. The Trend of Increasing Placebo Response and Decreasing Treatment Effect in Schizophrenia Trials Continues: An Update from the US Food and Drug Administration. J Clin Psychiatry. 2020;81(2). PMID: 3214172.

Complete List of Published Work in MyBibliography

Recent Presentations at Conferences

  1. Athanasios Chamzas, Kannan Sridharan, Mathangi Gopalakrishnan. Patent Ductus Arteriosus in Preterm Infants: Exploring Optimal Acetaminophen Dosing for Oral and Rectal Administration. American Conference on Pharmacometrics (ACoP), Phoenix, Arizona, November 2024.
  2. Sooyoung Lee, Mathangi Gopalakrishnan. Exploring Appropriate Prior Distributions for Covariance Matrix Estimation in Bayesian Population Pharmacokinetic Analysis. American Conference on Pharmacometrics (ACoP), Phoenix, Arizona, November 2024. Trainee Quality Award Winner.
  3. K V. Tobin, Bianca Reginauld, Audra L. Stinchcomb, Mathangi Gopalakrishnan. Flux-based IVIVC for predicting oxybutynin exposure with and without occlusion of a transdermal gel. American Conference on Pharmacometrics (ACoP), Phoenix, Arizona, November 2024.
  4. Babajide Shenkoya, Ahizechukwu Eke, Mathangi Gopalakrishnan. Pharmacokinetics of Long-Acting Naltrexone in Pregnancy: Insights from Physiologically Based Pharmacokinetic Modeling. American Conference on Pharmacometrics (ACoP), Phoenix, Arizona, November 2024.
  5. Athanasios Chamzas, Mathangi Gopalakrishnan, Osward M. Nyirenda, Nginache Nampota-Nkomba, Jane Mallewa, Rana Rais, Jesse Alt, Matthew Laurens, Douglas G. Postels, Brittany A. Riggle. American College of Clinical Pharmacology (ACCP), Bethesda, MD. September 2024.